1700 Minor Ave Suite 1600, Seattle, WA 98101
pamela.a.shaw@kp.org
Home
PI
About
Research
Publications
Book
Shaw Lab
About
People
(Sh)
2
Collaborative
About
People
Research
Publications
Software
News
Contact
Search
Infectious Disease
Marques A, Shaw P, Schmid CH, Steere A, Kaplan RF, Hassett A, Shapiro E, Wormser GP. Re: A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Prolonged Lyme disease treatment: enough is enough [Commentary]. Neurology, 2009 Jan 27;72 (4):383-4.
March 29, 2021
Hassim S, Shaw PA, Sangweni P, Malan L, Ntshani E, Mathibedi MJ, Stubbs N, Metcalf JA, Eckes R, Masur H, Komati S. Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples. Clinical Infectious Diseases, 2010 Apr 1; 50(7): 1053-9.
March 29, 2021
Greenberg DE, Marshall-Batty KR, Brinster LR, Zarember KA, Shaw PA, Mellbye BL, Iversen PL, Holland SM, and Geller BL. Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex. Journal of Infectious Diseases, 2010 Jun; 201 (12): 1822-30.
March 29, 2021
Komati S, Shaw PA, Stubbs N, Mathibedi MJ, Malan L, Metcalf JA, Masur H, Hassim S. Tuberculosis risk factors and mortality for HIV infected persons receiving antiretroviral therapy in South Africa. AIDS, 2010 Jul 31; 24 (12): 1849-55.
March 29, 2021
Shaw PA Combination versus monotherapy for septic shock patients [Commentary]. Critical Care Medicine. 2010 Sep; 38 (9): 1905-6.
March 29, 2021
Prevots DR, Shaw PA Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seltz AE, Holland SM Olivier KN. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. American Journal of Respiratory Critical Care Medicine 2010 Oct 1; 182 (7): 970-6.
March 29, 2021
Zarember KA, Marshall-Batty KR, Cruz AR, Chu J, Fenster ME, Shoffner AR, Rogge LS, Whitney AR, Czapiga M, Song HH, Shaw PA, Nagashima K, Malech HL, DeLeo FR, Holland SM, Gallin JI, Greenberg DE. Innate immunity against Granulibacter bethesdensis, an emerging Gram-negative bacterial pathogen, Infection and Immunity, 2012 Mar; 80 (3) 975-981.
March 29, 2021
Carroll MW, Lee M, Cai Y, Hallahan CW, Shaw PA, Min JH, Goldfeder LC, Alekseyev V, Grinkrug S, Kang HS, Hwang S, Park HM, Kang E, Lee SY, Jin B, Park HE, Min S, Park SK, Jeon DS, Via LE, Barry CE 3rd. Frequency of Adverse Reactions to First- and Second-line Anti-tuberculosis Chemotherapy in a Korean cohort. The International Journal of Tuberculosis and Lung Disease, 2012 Jul;16(7):961-6.
March 29, 2021
Greenberg DE, Shoffner AR, Marshall-Batty KR, Arora K, Zhao M, Martin R, Ding L, Hammer CH, Shaw PA, Kuhns DB, Malech HL, Gallin JI, Zaramber KA, Holland SM. Serologic Reactivity to the Emerging Pathogen Granulibacter bethesdensis. Journal of Infectious Diseases. 2012 Sep 15;206(6):943-51.
March 29, 2021
Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Heon HS, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee JK, Lee DH, Kim CT, Dartois V, Park SK, Cho SN, Barry CE. Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis. New England Journal of Medicine, 2012 Oct 18; 367(16):1508-1518.
March 29, 2021
1
2
3